Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1

Status

Completed 22Terminated 4Recruiting 4Withdrawn 2Unknown 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Head & Neck 2

Conditions

Oropharyngeal Neoplasms 1Neuralgia 1Head and Neck Neoplasms 1

Interventions

Cyclophosphamide 129Cisplatin 119Radiotherapy 115pembrolizumab 111Carboplatin 97Paclitaxel 96Gemcitabine 96Magnetic Resonance Spectroscopy 80Nivolumab 76Bevacizumab 76Fluorouracil 74Dexamethasone 73Radiosurgery 66Docetaxel 59Rituximab 58Leucovorin 57Oxaliplatin 55Capecitabine 55Biopsy 53Doxorubicin 52fludarabine 51Drug Therapy 45durvalumab 44Cytarabine 44Etoposide 42fludarabine phosphate 40Pemetrexed 40Radiation 39atezolizumab 36Surveys and Questionnaires 36

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Withdrawn × Gabapentin × Clear all
NCT03747562 2024-09-19

stREnGTH

University Hospital, Ghent

Phase 3 Withdrawn
Head & Neck

Head and Neck Neoplasms, Neuralgia

NCT03423264 2024-07-31

PROGRESS Trial - Prophylactic Gabapentin for Relief of Symptoms and Improved Swallowing

University of Chicago

Phase 2 Withdrawn
Head & Neck

Oropharyngeal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡